Kathrin Weller, MD
Physical Medicine and Rehabilitation · Eugene, ORNPI 1497714273
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $265 and has fallen 80.5% since, to $52 in 2025.
Across 45 payments — averaging $23.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$148
- Amgen$144
- Collegium Pharmaceutical, Inc.$134
- Merz Pharmaceuticals, LLC$110
- Ipsen Biopharmaceuticals, Inc$106
- AbbVie$99
- plus $331 from 8 others
What the payments were for
- Food & beverage$1,04397%
- Education$293%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 3 | $148 |
| Amgen | 7 | $144 |
| Collegium Pharmaceutical, Inc. | 8 | $134 |
| Merz Pharmaceuticals, LLC | 3 | $110 |
| Ipsen Biopharmaceuticals, Inc | 4 | $106 |
| AbbVie(2 entities) | 6 | $99 |
| Argenx US, Inc. | 2 | $70 |
| Bioventus LLC | 2 | $60 |
| Tanabe Pharma America, Inc. | 2 | $50 |
| Pfizer | 3 | $47 |
| Vertical Pharmaceuticals, LLC | 2 | $37 |
| Otto Bock Healthcare LP | 1 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Abbott | 1 | $15 |
How this compares
$1,072 in reported general payments places this provider in the 80th percentile of 85 physical medicine and rehabilitation providers in Oregon.
See all physical medicine and rehabilitation providers in Oregon →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 13 | $14,868 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 170 | $5,081 |
| Gabapentin | 166 | $4,447 |
| Fentanyl | 22 | $2,738 |
| Morphine Sulfate ErMorphine Sulfate | 41 | $1,510 |
| Tizanidine Hcl | 56 | $1,344 |
| Baclofen | 64 | $1,106 |
| Oxycodone Hcl | 93 | $1,025 |
| Methadone Hcl | 24 | $852 |
| Duloxetine Hcl | 62 | $792 |
| Pregabalin | 44 | $650 |
| Tramadol Hcl | 34 | $597 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $377 |
| Meloxicam | 42 | $224 |
| Hydromorphone Hcl | 15 | $180 |
Paid to pharmacies, not to this prescriber.
Other physical medicine and rehabilitation in Eugene
- Jedediah RobinsonEugene$4K
- James KassubeEugene$3K
- Robert ArnsdorfEugene$2K
- Victor LinEugene$1K
- William GalbraithEugene$153
- Catherine DaltonEugene$144
- Roy BlackburnEugene$91
- Habib FannyEugene$29
- Bryan AndresenEugene$19
- Mary LindquistPortland$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.